Top Markets
#1 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +18.70%
#2 Ontology Gas Ontology Gas +17.76%
#3 GoPlus Security GoPlus Security +9.80%
#4 Janction Janction +9.64%
#5 DMT-NAT DMT-NAT +7.80%
#6 Provenance Blockchain Provenance Blockchain +6.63%
#7 B3 (Base) B3 (Base) +6.09%
#8 Ontology Ontology +6.08%
#9 Status Status +5.87%
#10 Everything Everything +5.64%
Coin of the day
FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock)
Paramètres
Langue
FRANçAIS
Devise
USD
Thème
Kineta, Inc. Kineta, Inc.

Kineta, Inc.

KA
Classement en actions #34153
Kineta, Inc. is a clinical-stage biotechnology firm dedicated to developing... Kineta, Inc. is a clinical-stage biotechnology firm dedicated to developing immunotherapies, with a focus on oncology, neuroscience, and biodefense applications. The company engages in partnerships with a variety of entities, including private companies, government bodies, and other industry stakeholders. Among its significant strategic collaborators are Pfizer, Genentech, Wellcome, and Samsung Biologics Co., Ltd. Established in 2007, Kineta, Inc. was previously known as Lecura, Inc. and has its base of operations in Seattle, Washington.
Prix de l'action
$0.617
Dernière synchronisation: 2024-10-14
Capitalisation boursière
$6.13M
Changement (1 jour)
0.49%
Changement (1 an)
0.00%
Pays
US
Échange Kineta, Inc. (KA)

Catégorie

Healthcare
Ratio P/B pour Kineta, Inc. (KA)
Ratio P/B au August 2026 TTM : -0.58
Selon les derniers rapports financiers et le cours de l'action de Kineta, Inc., le ratio cours/valeur comptable actuel (TTM) est -0.58. À la fin de 2023, le ratio P/B était de 13.88.
Historique du ratio P/B pour Kineta, Inc. de 2015 à 2026
Ratio P/B à la fin de chaque année
Année Ratio P/B Changez
2026 (TTM) -0.58 -6.79%
2024 -0.62 -104.47%
2023 13.88 96.37%
2022 7.07 -463.47%
2021 -1.95 36.18%
2020 -1.43 -198.50%
2019 1.45 71.37%
2018 0.85 -49.33%
2017 1.67 -23.75%
2016 2.19 -92.84%
2015 30.60 0.00%
Ratio P/B pour des entreprises similaires ou concurrentes
Entreprise Ratio P/B Différence de Ratio P/B Pays
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 6.3419 -1,197.40%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 6.2413 -1,180.00%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 3.4612 -698.93%
BE